Lee, J. M., Lee, M., Garon, E. B., Goldman, J. W., Salehi-Rad, R., Baratelli, F. E., . . . Dubinett, S. M. (2017). Phase I trial of intratumoral injection of CCL21 gene modified dendritic cells in lung cancer elicits tumor-specific immune responses and CD8(+) T cell infiltration. Clin Cancer Res.
Chicago Stili AlıntıLee, Jay M., et al. "Phase I Trial of Intratumoral Injection of CCL21 Gene Modified Dendritic Cells in Lung Cancer Elicits Tumor-specific Immune Responses and CD8(+) T Cell Infiltration." Clin Cancer Res 2017.
MLA AlıntıLee, Jay M., et al. "Phase I Trial of Intratumoral Injection of CCL21 Gene Modified Dendritic Cells in Lung Cancer Elicits Tumor-specific Immune Responses and CD8(+) T Cell Infiltration." Clin Cancer Res 2017.